• SPX
  • $5,893.62
  • 0.39 %
  • $23.00
  • DJI
  • $43,389.60
  • -0.13 %
  • -$55.39
  • N225
  • $38,429.37
  • 0.55 %
  • $208.52
  • FTSE
  • $8,109.32
  • 0.57 %
  • $45.71
  • IXIC
  • $18,791.81
  • 0.6 %
  • $111.69
Renovacor, Inc. (RCOR) Stock Price, News & Analysis

Renovacor, Inc. (RCOR) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$2.94
Day's range
$3.2
50-day range
$1.85
Day's range
$3.365
  • Country: US
  • ISIN: US75989E1064
52 wk range
$1.34
Day's range
$9.01
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score N/A
  • Piotroski Score N/A
  • Grade Buy
  • Symbol (RCOR)
  • Company Renovacor, Inc.
  • Price $3.20
  • Changes Percentage (4.92%)
  • Change $0.15
  • Day Low $2.94
  • Day High $3.20
  • Year High $9.01

Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). The company's lead product candidate is REN-001, a recombinant adeno-associated virus 9-based gene therapy designed to deliver a functional BAG3 gene to augment BAG3 protein levels in cardiomyocytes, and slow or halt progression of BAG3 DCM. It is also developing a pipeline of BAG3-associated gene therapies for diseases with high unmet medical need associated with mutations in the BAG3 gene and mechanistically linked to BAG3's expression and function. The company was founded in 2013 and is based in Greenwich, Connecticut.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) N/A
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.47
  • Trailing P/E Ratio -6.7510548523207
  • Forward P/E Ratio -6.7510548523207
  • P/E Growth -6.7510548523207
  • Net Income $0

Income Statement

Quarterly

Annual

Latest News of RCOR

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Renovacor, Inc. Frequently Asked Questions

  • What is the Renovacor, Inc. stock price today?

    Today's price of Renovacor, Inc. is $3.20 — it has increased by +4.92% in the past 24 hours. Watch Renovacor, Inc. stock price performance more closely on the chart.

  • Does Renovacor, Inc. release reports?

    Yes, you can track Renovacor, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Renovacor, Inc. stock forecast?

    Watch the Renovacor, Inc. chart and read a more detailed Renovacor, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Renovacor, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on AMEX, exchange stock trades by Renovacor, Inc. stock ticker.

  • How to buy Renovacor, Inc. stocks?

    Like other stocks, RCOR shares are sold on stock exchanges such as AMEX. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Renovacor, Inc.'s EBITDA?

    Renovacor, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Renovacor, Inc.’s financial statements.

  • Should I invest in Renovacor, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Renovacor, Inc.'s financials relevant news, and technical analysis. Renovacor, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Renovacor, Inc. stock currently indicates a “sell” signal. For more insights, review Renovacor, Inc.’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.